An Actin-Binding Protein of the Sla2/Huntingtin Interacting Protein 1 Family Is a Novel Component of Clathrin-Coated Pits and Vesicles by Engqvist-Goldstein, Åsa E.Y. et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/99/12/1503/16 $5.00
The Journal of Cell Biology, Volume 147, Number 7, December 27, 1999 1503–1518
http://www.jcb.org 1503
 
An Actin-binding Protein of the Sla2/Huntingtin Interacting Protein 1 
Family Is a Novel Component of Clathrin-coated Pits and Vesicles
 
Åsa E.Y. Engqvist-Goldstein,* Michael M. Kessels,* Vikramjit S. Chopra,
 
‡
 
 Michael R. Hayden,
 
‡
 
and David G. Drubin*
 
*Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720-3202; and 
 
‡
 
Centre 
for Molecular Medicine and Therapeutics, Department of Medical Genetics, Children’s and Women’s Hospital, University of 
British Columbia, Vancouver, British Columbia, Canada V5Z 4H4
 
Abstract. 
 
The actin cytoskeleton has been implicated 
in endocytosis, yet few molecules that link these sys-
tems have been identiﬁed. Here, we have cloned and 
characterized mHip1R, a protein that is closely related 
to huntingtin interacting protein 1 (Hip1). These two 
proteins are mammalian homologues of Sla2p, an actin 
binding protein important for actin organization and 
endocytosis in yeast. Sequence alignments and second-
ary structure predictions veriﬁed that mHip1R belongs 
to the Sla2 protein family. Thus, mHip1R contains an 
NH
 
2
 
-terminal domain homologous to that implicated in 
Sla2p’s endocytic function, three predicted coiled–coils, 
a leucine zipper, and a talin-like actin-binding domain 
at the COOH terminus. The talin-like domain of 
mHip1R binds to F-actin in vitro and colocalizes with 
F-actin in vivo, indicating that this activity has been 
conserved from yeast to mammals. mHip1R shows a 
punctate immunolocalization and is enriched at the cell 
cortex and in the perinuclear region. We concluded that 
the cortical localization represents endocytic compart-
ments, because mHip1R colocalizes with clathrin, AP-2, 
and endocytosed transferrin, and because mHip1R 
fractionates biochemically with clathrin-coated vesicles. 
Time-lapse video microscopy of mHip1R–green ﬂuo-
rescence protein (GFP) revealed a blinking behavior 
similar to that reported for GFP-clathrin, and an actin-
dependent inward movement of punctate structures 
from the cell periphery. These data show that mHip1R 
is a component of clathrin-coated pits and vesicles and 
suggest that it might link the endocytic machinery to 
the actin cytoskeleton.
Key words: actin • endocytosis • clathrin • Hunting-
ton disease • vesicle
 
E
 
NDOCYTOSIS
 
 is important for receptor internaliza-
tion, nutrient uptake, antigen presentation, patho-
gen internalization, and maintenance of plasma
membrane surface area (for reviews see Riezman et al.,
1997; Marsh and McMahon, 1999). Endocytosis occurs via
several distinct pathways and requires coordinated inter-
actions between a variety of molecules at the cell cortex.
In yeast, a functional connection between the actin cyto-
skeleton and endocytosis has been firmly established (for
reviews see Geli and Riezman, 1998; Wendland et al., 1998).
Mutations in actin and in several actin-binding proteins in-
hibit the internalization step of both receptor-mediated
and fluid-phase endocytosis (Kübler and Riezman, 1993;
Raths et al., 1993; Munn et al., 1995). Furthermore, studies
using actin mutants and cofilin mutants suggest that rapid
actin filament turnover is required for endocytosis (Lap-
palainen and Drubin, 1997; Belmont and Drubin, 1998). In
mammalian cells, a role for actin in endocytosis has not
been as clearly established. Cytochalasin-D, a drug that
destabilizes actin filaments, inhibits apical endocytosis in
polarized epithelial cells but has no effect on basolateral
endocytosis (Gottlieb et al., 1993; Jackman et al., 1994). In
other cell types, there are conflicting results on the effects
of various actin-depolymerizing drugs on receptor-medi-
ated endocytosis (Salisbury et al., 1980; Wolkoff et al.,
1984; Sandvig and van Deurs, 1990; Lamaze et al., 1996,
1997).
Several functional roles for actin in endocytic processes
have been proposed. The actin cytoskeleton might provide
a force for vesicle budding, or it might mediate vesicle
transport or fusion (Gottlieb et al., 1993; Lamaze et al.,
1997; Merrifield et al., 1999). Alternatively, it might pro-
vide a scaffold at the plasma membrane for the endocytic
machinery (Wendland et al., 1998; Gaidarov et al., 1999).
To gain further insight into the role of the actin cyto-
skeleton in endocytosis, it is important to identify proteins
that link the actin cytoskeleton to the endocytic machin-
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ery. In yeast, mutations of several actin-binding proteins
cause defects in both endocytosis and in the organization
of the actin cytoskeleton. One such protein is Sla2p, which
was first identified in a synthetic lethal screen against a
null allele of 
 
ABP1
 
 (Holtzman et al., 1993), a gene encod-
ing an actin-binding protein implicated in cytoskeletal reg-
ulation, endocytosis, and cAMP signaling (Drubin et al.,
1988; Wesp et al., 1997). Sla2p, also known as End4p and
Mop2p, is a peripheral membrane protein that contains a
novel NH
 
2
 
-terminal domain, three putative coiled–coil do-
mains, a putative leucine zipper, and a COOH-terminal
talin-like domain (Holtzman et al., 1993; Raths et al., 1993;
Na et al., 1995; Wesp et al., 1997; Yang et al., 1999). Sla2p
binds to F-actin in vitro through the talin-like domain and
partially colocalizes with F-actin in cortical patches (Mc-
Cann and Craig, 1997; Yang et al., 1999). Interestingly,
Sla2p localizes to the cell cortex in the presence of latrun-
culin-A (LAT-A),
 
1
 
 indicating that Sla2p has an actin-inde-
pendent cortical localization signal (Ayscough et al., 1997).
Sla2p has been implicated in endocytosis (Raths et al.,
1993), membrane protein maintenance (Na et al., 1995),
and vesicle trafficking (Mulholland et al., 1997).
Homologues of Sla2p have been identified in nematodes
(
 
ZK370
 
.
 
3
 
) and humans (Hip1R) (Holtzman et al., 1993;
Seki et al., 1998), but very little is known about their cellu-
lar functions. In mammals, an additional isoform exists,
the huntingtin interacting protein 1 (Hip1), which is pre-
dominantly expressed in the brain (Kalchman et al., 1997;
Wanker et al., 1997). Huntington disease is an inherited
neurodegenerative disorder caused by expansion of the
codon CAG in the huntingtin gene, which leads to expres-
sion of a polyglutamine tract in the protein (for reviews
see Wellington et al., 1997; Reddy et al., 1999). The affin-
ity of the huntingtin protein–Hip1 interaction is inversely
correlated to the polyglutamine length. Therefore, it has
been speculated that loss of normal huntingtin–Hip1 inter-
action might contribute to a defect in membrane–cytoskel-
etal integrity in the brain (Kalchman et al., 1997). To learn
more about the cellular function of the Sla2 family of pro-
teins, we have initiated a study of the mouse homologue of
Hip1R.
 
Materials and Methods
 
Cloning of mHip1R
 
A mouse brain lambda ZAPII cDNA library (#936314; Stratagene) was
screened using a mouse expressed sequence tag (EST) obtained from
American Tissue Culture Collection (ESTm1; sequence data available
from EMBL/GenBank/DDBJ under accession no. W82687). 50 ng of a
1.3-kb EcoRI/NcoI fragment of this EST was radioactively labeled with
[
 
32
 
P]dCTP using random-priming. The probe was allowed to hybridize to
filters containing 
 
.
 
2 
 
3
 
 10
 
5
 
 pfu/ml of the mouse brain lambda ZAPII
cDNA library, and incubated overnight at 65
 
8
 
C in Church buffer (0.5 M
NaPO
 
4
 
, 7% SDS, 1 mM EDTA, pH 7.4). The filters were washed at room
temperature for 15 min with 2
 
3
 
 SSPE (200 mM NaH
 
2
 
PO
 
4
 
, 3 M NaCl, 25
mM EDTA, pH 7.4) containing 0.1% SDS, then at 65
 
8
 
C for 20 min with
1
 
3
 
 SSPE (200 mM NaH
 
2
 
PO
 
4
 
, 3 M NaCl, 25 mM EDTA, pH 7.4), contain-
ing 0.1% SDS, and finally twice at 65
 
8
 
C with 0.2
 
3
 
 SSPE, containing 0.1%
SDS. The filters were exposed to X-ray film overnight at 
 
2
 
70
 
8
 
C. Primary
positives were isolated, replated, and subsequent secondary positives were
 
hybridized and washed as for the primary screen. The resulting positive
phage was converted into plasmid DNA by conventional methods (Strat-
agene) and the cDNA (3.96 kb) encoding mHip1R was isolated and com-
pletely sequenced.
 
DNA Constructions
 
Two murine ESTs were obtained from American Tissue Culture Collec-
tion, ESTm1 and ESTm2 (sequence data available from EMBL/Gen-
Bank/DDBJ under accession nos. W82687 and AA10840, respectively).
The plasmid DNA was isolated and sequenced. These EST clones and the
full-length mHip1R cDNA (see above) were used to generate the differ-
ent constructs in this study.
For the antibody production and for in vitro actin-binding assays, frag-
ments of mHip1R were expressed as glutathione 
 
S
 
-transferase (GST) fu-
sion proteins in 
 
E
 
.
 
 coli
 
. mHip1R (amino acids [aa] 1015–1068) was ampli-
fied by PCR using primers that generate NcoI and EcoRI sites at the 5
 
9
 
and 3
 
9
 
 ends, respectively. mHip1R (aa 766–1068) was amplified using
primers that generate XhoI and HindIII sites at the 5
 
9
 
 and 3
 
9
 
 ends, respec-
tively. The PCR products were cut with the above restriction enzymes and
ligated into the pGAT2 vector (a GST fusion derivative of pBAT;
Peränen et al., 1996).
For expression of mHip1R constructs in mammalian cells, full-length
protein (aa 1–1068) and fragments of mHip1R were expressed as green
fluorescence protein (GFP) fusions, or were expressed with a 6 myc-tag at
the COOH terminus. mHip1R (aa 1–1068)–GFP and mHip1R (aa 1–324)–
GFP were amplified by PCR using primers that generate NheI and SalI
sites at the 5
 
9
 
 and 3
 
9
 
 ends, respectively. The PCR products were ligated
into pEGFP-N1 (Clontech, Inc.). The linker region created between
mHip1R and GFP consists of the 14 aa QSTVPRARDPPVAT. mHip1R
(aa 1–1068)–GFP, mHip1R (aa 346–1068)–GFP, and mHip1R (aa 766–
1068)–GFP were amplified by PCR using primers that generate XhoI and
XbaI sites at the 5
 
9
 
 and 3
 
9
 
 ends, respectively. The PCR products were li-
gated into pEGFP-C1 (Clontech, Inc.). A linker region of 10 aa (SGL-
RSRAGGS) was created between GFP and mHip1R. mHip1R (aa
1–1068)–6 myc, mHip1R (aa 1–324)–6 myc, mHip1R (aa 1–655)–6 myc,
mHip1R (aa 346–1068)–6 myc, and mHip1R (aa 766–1068)–6 myc were
amplified by PCR using primers that generate ClaI and NotI sites at the 5
 
9
 
and 3
 
9
 
 ends, respectively. The PCR products were ligated into a 6 myc de-
rivative of pIRESneo (Clontech, Inc.). This vector was created by cloning
a 6 myc-tag into the Not1 and BamH1 sites of the pIRESneo vector. This
created a linker region between the mHip1R sequence and the 6 myc-tag
consisting of 5 aa (SRPQAM). A Kozac site including the ATG was
added to constructs that do not contain the NH
 
2
 
 terminus. All constructs
were sequenced to ensure that no mutations were introduced during PCR.
In addition, all constructs were tested for expression by Western blotting
(see below).
 
Northern Blot Analysis of mHip1R mRNA
 
Northern blot analyses of mHip1R mRNA levels were performed using
blots containing either 2 
 
m
 
g RNA per lane from eight different tissues or
RNA from mouse embryos at four different embryonic stages (Clontech,
Inc.). A 297-bp DNA fragment corresponding to mHip1R (aa 970–1068)
was amplified by PCR using ESTm1 as a template. To generate a probe,
this DNA fragment was labeled with [
 
a
 
-
 
32
 
P]CTP (Amersham Pharmacia
Biotech) using an oligonucleotide labeling kit which employs Klenow
polymerase (Amersham Pharmacia Biotech). Unincorporated nucleotides
were removed using MicroSpin S-200 columns (Amersham Pharmacia
Biotech). 37.5 ng of the labeled probe (sp act 
 
5 
 
8 
 
3
 
 10
 
5
 
 cpm/ng) were used
per blot. The blots were prehybridized in ExpressHyb solution (Clontech,
Inc.) for 30 min at 68
 
8
 
C. The probe was then added to the prehybridized
blots and incubated at 68
 
8
 
C for 1.5 h. The blots were then washed at room
temperature three times for 1 min and three times for 10 min in 300 mM
NaCl, 30 mM sodium citrate, pH 7.0, containing 0.05% SDS, and were
subsequently washed at 50
 
8
 
C twice for 20 min with prewarmed 15 mM
NaCl, 1.5 mM sodium citrate, pH 7.0, containing 0.1% SDS. mHip1R mRNAs
were detected by exposing the blots for 7–8 d on autoradiography film. A
probe derived from a human 
 
b
 
-actin cDNA (Clontech, Inc.) was used to
control for RNA loading and integrity. Blots were reused after stripping
them in 0.5% SDS at 90–100
 
8
 
C for 10 min under frequent rocking. Com-
pletion of stripping was verified by autoradiography.
 
Production of Polyclonal Anti-mHip1R Antibodies
 
Polyclonal guinea pig antisera were raised against a nonconserved region
 
1. 
 
Abbreviations used in this paper:
 
 aa, amino acid(s); EST, expressed
sequence tag; GFP, green fluorescence protein; GST, glutathione 
 
S
 
-trans-
ferase; Hip1, huntingtin interacting protein 1; LAT-A, latrunculin-A. 
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at the COOH terminus of mHip1R (aa 1032–1068). mHip1R (aa 1015–1068)
was expressed as a GST fusion in 
 
E
 
.
 
 coli
 
. The protein was purified us-
ing glutathione–affinity chromatography, cleaved with thrombin (Sigma
Chemical Co.) and purified by gel filtration followed by HPLC. This pro-
cedure yielded a degradation product of high purity (aa 1032–1068, as
identified by mass spectrometry). This polypeptide was then conjugated to
guinea pig albumin and mixed with Ribi adjuvant (R-700; Ribi Immu-
noChem Research, Inc.) for injection into Hartley guinea pigs (100 
 
m
 
g
protein per injection). After the initial injection, boosts were given every
3–4 wk. The crude sera were screened against 0.5–500 ng of purified
mHip1R (aa 765–1068) and against mouse tissue homogenates by immu-
noblotting. After five injections, the crude antiserum was purified by af-
finity chromatograpy as described by Kozminski et al. (2000). In brief,
mHip1R (aa 1015–1068)–GST was conjugated to Reacti-Gel™
 
 
 
(Pierce)
following the manufacturer’s instructions, and poured into a column. The
column was washed and the crude serum was circulated through the col-
umn overnight. After extensive washing, the antiserum was eluted with
0.05 M Tris-HCl, 4.5 M MgCl
 
2
 
, 1 mg/ml BSA, pH 7.4. This antibody is re-
ferred to as GP#8.
 
Immunoblot Analysis of mHip1R
 
Tissues for Western blotting were harvested from adult female Swiss
Webster mice and immediately frozen in liquid nitrogen. The different tis-
sues and organs were minced using a razor blade, and homogenized at 4
 
8
 
C
using a dounce glass homogenizer (size AA; 
 
z
 
20 strokes). For homogeni-
zation, 3 ml/g tissue homogenization buffer A (250 mM sucrose, 10 mM
EGTA, 2 mM EDTA, 20 mM Tris, pH 7.5) containing a protease inhibitor
cocktail A (10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml aprotinin, 10 
 
m
 
g/ml soybean
trypsin inhibitors, and 1 mM PMSF) was used. The samples were centri-
fuged at 4
 
8
 
C for 20 min at 4,000 rpm in a microcentrifuge. The resulting
supernatants were used for Western blot analysis, in which equal amounts
of protein were loaded in each lane.
Cell line homogenates were prepared by growing cells to confluence,
rinsing the cells with ice-cold PBS, scraping the cells off the plates, collect-
ing them by centrifugation, and lysing the cell pellets in ice cold homoge-
nization B (150 mM NaCl, 2 mM EDTA, 1% NP-40, 50 mM Hepes, pH
7.5) supplemented with the protease inhibitor cocktail A at 350 
 
m
 
l/5 
 
3
 
 10
 
6
 
cells. The crude homogenate was then dounced as described above, and
spun for 5 min at 5,000 rpm at 4
 
8
 
C in a microcentrifuge.
SDS-PAGE was performed and proteins were transferred to nitrocel-
lulose membranes in transfer buffer containing 0.05% SDS. Membranes
were then blocked for 1.5 h with TBS/0.05% Tween 20 containing 5%
nonfat milk, followed by incubation with affinity-purified anti-mHip1R
antiserum. The primary antibodies were visualized using HRP-conjugated
anti–guinea pig secondary antibodies (ICN Pharmaceuticals, Inc.) and en-
hanced chemiluminescence (Amersham Pharmacia Biotech).
 
In Vitro Actin-binding Assay
 
The talin-like domain of mHip1R (aa 766–1068) was expressed as a GST
fusion in 
 
E
 
.
 
 coli
 
 Bl21 (DE3) cells using the pGAT2 plasmid constructs de-
scribed above. Cultures were grown to OD
 
600
 
 
 
5 
 
0.5 and expression was
induced by addition of 0.4 mM isopropyl-thio-
 
b
 
-
 
D
 
-galactoside (IPTG;
Sigma Chemical Co.). Cells were lysed by one freeze–thaw cycle, followed
by sonication (six times for 20 s) in PBS containing 10 mM EGTA and
0.5 mM PMSF. The GST fusion protein was purified using glutathione–
affinity chromatography as described by Ausubel et al. (1994). The puri-
fied GST–talin-like domain was then used in an actin filament cosedimen-
tation assay. Actin filaments were assembled as described by Goode et al.
(1999) with minor alterations. In brief, 0.1 vol of 10
 
3
 
 initiation mix (20 mM
MgCl
 
2
 
, 0.5 M KCl, 5 mM ATP) was added to human nonmuscle mono-
meric actin (Cytoskeleton) in G-buffer (5 mM Tris, pH 7.5, 0.2 mM ATP,
0.2 mM DTT, and 0.2 mM CaCl
 
2
 
), and was then incubated for 30 min at
20
 
8
 
C. The cosedimentation assays were performed using 50-
 
m
 
l reactions
containing 1.25–10 
 
m
 
M 
 
a
 
-actin and 1.5 
 
m
 
M GST–talin-like domain. The
mixtures were centrifuged for 25 min at 90,000 rpm at 20
 
8
 
C in a TLA100
rotor (Beckman). Pellets and supernatants were resuspended in SDS sam-
ple buffer and equal volumes were analyzed by SDS-PAGE, followed by
Coomassie blue staining. Protein amounts was quantified using an IS-100
densitometer (Alpha Innotech Corp.).
 
Cell Culture
 
NIH/3T3, COS-7, and MDCK cells were maintained in DME (GIBCO
BRL) containing 10% FBS.
 
Indirect Immunofluorescence
 
Cells grown on glass coverslips were washed with 50 mM MES, pH 6.1, 5 mM
MgCl
 
2
 
, 3 mM EGTA, 5 mM glucose, and were then incubated with 3–4%
formaldehyde, 0.1% glutaraldehyde in the same buffer for 35–45 min. The
fixed cells were quenched with 1 mg/ml NaBH
 
4
 
 (twice for 10 min) to pre-
vent autofluorescence, and then blocked and permeabilized with TBS
(20 mM Tris, pH 7.5, 154 mM NaCl, 2 mM EGTA, 2 mM MgCl
 
2
 
) contain-
ing 2% BSA and 0.02% saponin for 1.5 h. The coverslips were then incu-
bated on 20-
 
m
 
l droplets of primary antibody diluted in TBS/BSA/saponin
overnight. The following primary antibodies were used: polyclonal anti-
GFP antibody (kindly provided by Dr. Pam Silver, Dana Farber Cancer
Institute, Harvard Medical School, Boston, MA); polyclonal anti-mHip1R
(see above); monoclonal anti–AP-2 antibody (AP-6) and monoclonal an-
ticlathrin antibody (X22) (Affinity Bioreagents); monoclonal anticlathrin
antibody (Transduction Laboratories); monoclonal anti-paxillin antibody
(Transduction Laboratories); polyclonal anti-Abp1 antibody (Kessels et al.,
2000); and monoclonal anti-myc antibody 9E10 (Santa Cruz Biotechnol-
ogy). After incubation with the primary antibodies, the coverslips were
washed three times for 15 min with TBS/BSA/saponin, and incubated with
the secondary antibodies in TBS/BSA/saponin for 1.5 h. The following
secondary antibodies were used: FITC goat anti–guinea pig (ICN Pharma-
ceuticals, Inc.); rhodamine goat anti–guinea pig (ICN Pharmaceuticals,
Inc.); FITC donkey anti–mouse (Jackson ImmunoResearch Laborato-
ries); rhodamine donkey anti–mouse (Jackson ImmunoResearch Lab-
oratories); FITC goat anti–rabbit (ICN Pharmaceuticals, Inc.); and
rhodamine sheep anti–rabbit (Cappel), and/or rhodamine-phalloidin (Mo-
lecular Probes). After incubation in secondary antibodies, the coverslips
were washed in TBS/BSA/saponin (15 min) and with TBS (twice for 15
min). After removing excess buffer, the coverslips were mounted onto
glass slides using VectaShield mounting medium containing 4,6-diami-
dino-2-phenylindole dihydrochloride (Vector, Inc.), sealed with nail pol-
ish, and viewed using an inverted Nikon Eclipse TE300 fluorescence mi-
croscope or with a Zeiss 510 confocal laser scanning microscope. For
epifluorescence microscopy, images were captured using a cooled CCD
Hamamatsu ORCA camera and were recorded digitally (ImageProPlus;
Phase3 Imaging Systems). For confocal microscopy, images were captured
using Zeiss 510 software. All images were prepared for publication using
Adobe Photoshop software.
 
Transferrin Uptake Assay
 
COS-7 cells grown on glass coverslips were serum starved for 45 min at
37
 
8
 
C in DME. Cells were then incubated with 25 
 
m
 
g/ml human transferrin
conjugated to Texas red (Molecular Probes) in serum-free media for 1 h at
4
 
8
 
C. Subsequently, the coverslips were washed three times for 5 min with
ice-cold PBS, and then fixed with an ice-cold solution of 4% formalde-
hyde and 0.1% glutaraldehyde (0 min) or warmed to 37
 
8
 
C for 2, 5, 10, 15,
or 30 min before they were washed and fixed as described above. The
fixed cells were then incubated with anti-mHip1R antibody, followed by
FITC anti–guinea pig antibody and were examined by confocal micros-
copy as described above.
 
Transfection of COS-7 Cells with mHip1R Constructs
 
First, the expression of GFP fusion proteins and myc-tagged proteins was
verified by immunoblotting. Cells were plated at 300,000 cells/well (6-well
plates) on glass coverslips, 24 h before transfection. Transfections were
performed using the lipofectamine method according to the manufacturer
(GIBCO BRL). Typically, 1 
 
m
 
g of DNA per 1 ml transfection medium
was used, and transfections were performed for 5 h at 37
 
8
 
C. The solution
was then replaced by complete medium (DME containing 10% FBS) and
cells were harvested 48 h after transfection. Homogenization buffer (see
above) containing 1% Triton X-100 was added directly to the 6-well plates
and cells were scraped off and homogenized using a 25-gauge needle.
Cells were then centrifuged at 15,000 rpm for 20 min at 4
 
8
 
C in a microcen-
trifuge. The resulting pellets and supernatants were analyzed by immuno-
blotting using polyclonal anti-GFP antibodies or monoclonal anti-myc an-
tibodies.
Second, subcellular localization of GFP fusion proteins and myc-tagged
proteins was determined by indirect immunofluorescence. Cells were
transfected as described above and processed for immunofluorescence
24–36 h after transfection as described above. Constructs used in these ex-
periments are described above. 
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Subcellular Fractionation and Purification of
Clathrin-coated Vesicles
 
For subcellular fractionation, 0.7–0.8 g of mouse brain was homogenized
in homogenization buffer A (250 mM sucrose, 10 mM EGTA, 2 mM
EDTA, 20 mM Tris, pH 7.5) containing the protease inhibitor cocktail A
(1:1 wt/vol) and spun at 3,000 
 
g
 
 for 20 min. P1 contains unbroken cells, nu-
clei, mitochondria, and large plasma membrane pieces. The supernatants
(S1) were collected and spun at 25,000 
 
g
 
 for 30 min to generate P2 (small
plasma membrane pieces, ER, and endosomes) and S2. Supernatant S2
was spun at 176,000 
 
g
 
 for 1 h to generate P3 (light microsomes and small
vesicles) and S3 (soluble proteins). For extraction experiments, P2 was re-
suspended in homogenization buffer A containing either 1% Triton X-100
or 0.5 M NaCl. After incubation on ice for 30 min, the fractions were spun
at 25,000 
 
g
 
 for 30 min. The protein concentration of each fraction was de-
termined by the Bradford method (1976). Equal amounts of protein were
examined by SDS-PAGE and immunoblotting.
Purification of clathrin-coated vesicles was performed as described by
Lindner (1998) with minor alterations. In brief, 10 mouse brains (
 
z
 
5 g)
(Pel Freez Biologicals) were minced using a razor blade and homogenized
in 5 ml buffer C (0.1 M MES, 1.0 mM EGTA, 0.5 mM MgCl
 
2
 
, pH 6.5) con-
taining the protease inhibitor cocktail A. Postmitochondrial supernatants
(S1) were spun at 120,000 
 
g
 
 in a Type70 rotor (Beckman) for 50 min at 4
 
8
 
C
to prepare a microsomal pellet (P2). P2 was resuspended in 0.4 ml buffer
C containing the protease inhibitor cocktail A and homogenized by 10–15
strokes in a Potter-Elvehjem device. The resuspended P2 was mixed with
0.4 ml 12.5% ficoll–sucrose solution and spun at 43,000 
 
g
 
 in a TLA100.3
rotor (Beckman) for 40 min at 4
 
8
 
C. The resulting supernatant (S3) was
mixed with 1.8 ml buffer C containing the protease inhibitor cocktail A
and subsequently spun at 125,000 
 
g
 
 in a TLA100.3 rotor for 30 min at 4
 
8
 
C.
The pellet (V), which contains the enriched clathrin-coated vesicles, was
resuspended in 100 
 
m
 
l buffer C. The S4 fraction was TCA-precipitated
and resuspended in the same volume as the pellet (V). Samples were ana-
lyzed by SDS-PAGE followed by Coomassie blue staining and by West-
ern blotting as described above. Equivalent portions of P1, S1, P2, and S2,
corresponding to 
 
z
 
0.02% of each fraction, were loaded on the gel. For S3,
P3, S4, and V, equivalent portions corresponding to 
 
z
 
2% of the fraction
were loaded.
Figure 1. Analysis of
mHip1R sequence. (a) Com-
parison of the full-length aa
sequence identities of Sla2-
related proteins. The per-
centage identity for the two
most similar proteins is high-
lighted in bold. For hHip1R,
the cDNA sequence reported
by Ishikawa et al. (1998) was
used (KIAA0655 protein; se-
quence data available from
EMBL/GenBank/DDBJ un-
der accession no. AB014555).
(b) Sequence alignment of
the NH2-terminal domain in
Sla2-related proteins. Resi-
dues that are conserved in at
least four proteins are boxed.
For hHip1R, residue M179,
designated as the first me-
thionine by Seki et al. (1998),
is highlighted in bold. The up-
stream hHip1R sequence is
from Ishikawa et al. (1998).
The hHip1 sequence dis-
played represents a sequence
published by Kalchman et al.
(1997) (M82-A277), and a re-
cently identified upstream se-
quence (S1-D81) (Chopra,
V.S., unpublished results). (c)
Schematic diagram showing
mHip1R domain organiza-
tion. The three predicted
coiled–coil forming domains
and the leucine zipper are
indicated, as well as the
COOH-terminal talin-like
domain, and the NH2-termi-
nal domain. The Coils pro-
gram (Lupas et al., 1991) was
used to determine the proba-
bility of coiled–coil forma-
tion. 
Engqvist-Goldstein et al. 
 
Hip1R Endocytic and Cytoskeletal Protein
 
1507
 
The following antibodies were used in the above experiments: poly-
clonal anti–amphiphysin II antibody (kindly provided by Harvey T.
McMahon, Medical Research Council Laboratories, Cambridge, UK);
polyclonal anti-mHip1R antibody; monoclonal anticlathrin antibody (Trans-
duction Laboratories); monoclonal antipaxillin antibody (Transduction
Laboratories); polyclonal anti-Abp1 antibody; polyclonal eps15 antibody
(Santa Cruz Biotechnologies); monoclonal antiactin antibody C4 (ICN
Pharmaceuticals, Inc.); polyclonal anti-BiP 1 (StressGen Biotech Corp.);
and monoclonal anti-syntaxin 1 (Sigma Chemical Co.).
 
Imaging of mHip1R-GFP in Living Cells
 
NIH/3T3 fibroblasts were transfected with mHip1R (aa 1–1068)–GFP as
described above. The coverslips were transferred to F-12 media (GIBCO
BRL) containing 5% FCS and 10 mM Hepes, pH 7.4. Cells expressing low
to medium levels of GFP fusion protein were imaged using an inverted Ni-
kon Eclipse TE300 fluorescence microscope with a Nikon Plan Apo (1.4
NA) 100
 
3
 
 objective and a Hamamatsu ORCA cooled CCD camera. GFP
fluorescence was visualized with 1.5–20 s exposures using a B-2E/C (FITC)
filter set (Nikon). During the experiments, the coverslips were maintained
at 37
 
8
 
C using an aluminum chamber connected to a circulating water bath.
The light was shuttered to reduce photobleaching when exposure times
were 
 
.
 
2 s. For observation of LAT-A treatments, media containing 2 
 
m
 
M
LAT-A were added to the chamber. For observation of detergent-extracted
cells, 0.05 vol of Triton X-100 (20% vol/vol) were added to cells at frame
5–10 of continuous time-lapse recording (1.5 s per frame) and observed
for 
 
z
 
1 min.
 
Results
 
Identification and Sequence Analysis of a Mouse 
Homologue of Yeast Sla2p
 
To identify mammalian homologues of yeast Sla2p, we
performed a database search. Several EST clones from
mouse and human were identified that encoded either
Hip1 or a novel protein related to Hip1. Different EST
clones for this novel protein were obtained and sequenced.
ESTm1 was used to screen a mouse brain lambda ZAPII
cDNA library, and an 
 
z
 
4 kb cDNA was subsequently
identified. This cDNA contains a 3,204-kb open reading
frame predicted to encode a 119.5-kD protein (1068 aa).
Sequence alignments of this open reading frame with
other Sla2-related proteins from different organisms re-
vealed that it is highly homologous (91% identity over the
entire aa sequence) to the recently identified protein
Hip1R (human Hip1-related; Seki et al., 1998) (Fig. 1 a).
Because of the high identity and the similarity in tissue dis-
tribution between these two proteins (see below), we be-
lieve that the novel Sla2-related protein we identified is
Figure 2. Mouse mHip1R
mRNA and protein expres-
sion levels. (a) mHip1R
mRNA expression exam-
ined by Northern blotting
during the course of mouse
embryonic development.
The numbers at the top of
each lane represent days af-
ter fertilization. (b) mHip1R
mRNA expression in differ-
ent tissues of adult mice. The
Northern probe comprised
297 bp at the COOH termi-
nus corresponding to aa 970–
1068. (c and d) Actin expres-
sion is shown as a control for
RNA integrity and loading.
(e) mHip1R protein expres-
sion examined by Western
blotting in different cell lines.
Approximately 50 mg protein
from postnuclear tissue ho-
mogenates was loaded per
lane. (f) mHip1R protein ex-
pression in different adult
mouse tissues. Approxi-
mately 200 mg of protein was
loaded per lane. 
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the mouse ortholog of human Hip1R. Therefore, we de-
cided to call it mHip1R. However, one major difference
between these two proteins exists within the NH
 
2-terminal
domain: Seki et al. (1998) selected a start codon z180 aa
downstream from the start codon we selected. It is likely
that these aa are part of the translated coding sequence,
because they show strong homology to the first half of the
NH2-terminal domain that is highly conserved among
Sla2-related proteins (Fig. 1 b). mHip1R shows 24–60%
identity to the other Sla2-related proteins in this domain.
Additionally, we identified a Kozac translational initiation
consensus sequence at the start codon that we favor. Fi-
nally, the human clone identified by Ishikawa et al. (1998)
also contains the full NH2-terminal domain. However, it
remains possible that different spliced variants of Hip1R
exists in humans, which may explain the truncation of the
NH2-terminal domain in hHip1R reported by Seki et al.
(1998).
As shown in Fig. 1 c, the domain structure and predicted
coiled–coil domains of mHip1R are similar to those of all
other Sla2-related proteins. However, in contrast to Sla2p,
mHip1R does not contain a proline-rich region or a
glutamine-rich region. These regions also do not appear in
Sla2-related proteins from nematodes, mice, or humans.
mHip1R Is Ubiquitously Expressed in Mouse Tissues
Northern blot analysis of mouse embryos showed that
mHip1R mRNA levels do not change appreciably during
development (Fig. 2 a). Furthermore, the mRNA is de-
tected in all tissues tested, although the levels are lower in
skeletal muscle and heart (Fig. 2 b). This is in contrast
to hHip1 mRNA, which is highly enriched in the brain
(Kalchman et al., 1997), but it is consistent with results
from Ishikawa et al. (1998) and Seki et al. (1998), who
showed by RT-PCR that hHip1R is expressed in a wide
variety of human tissues. The size of the mHip1R mRNA
was z5 kb and varies slightly in different tissues (Fig. 2, a
and b). In addition, an z2-kb band was detected during
the early stage of embryonic development (Fig. 2 a).
Polyclonal antibodies were raised against the extreme
COOH terminus of mHip1R (aa 1032–1068), which is a re-
gion that is not conserved between any of the known Sla2-
related proteins. Our affinity-purified antibody detected a
band of z120 kD in all cell lines and tissues tested on
Western blots (Fig. 2, e and f). The mHip1R signal in skel-
etal muscle is extremely low (Fig. 2 f), which corresponds
well with the mRNA levels detected by Northern blotting.
Furthermore, the size of this protein corresponds to the
molecular weight predicted for mHip1R. This band was
not detected with preimmune serum or with anti-mHip1R
sera preincubated with the antigen (data not shown).
The Talin-like Domain of mHip1R Binds F-Actin In Vitro
McCann and Craig (1997) showed that yeast Sla2p binds
to F-actin in vitro through the talin-like domain. They
named this domain the I/LWEQ module due to the pres-
ence of several conserved residues (McCann and Craig,
1997). To test whether this binding activity is conserved in
mHip1R, the talin-like domain (aa 766–1068) was ex-
pressed in E. coli as a GST fusion and tested for actin
binding in an F-actin pelleting assay (Fig. 3 a). Expression
and solubility problems precluded the analysis of the full-
length protein. As shown in Fig. 3 b, the talin-like domain
of mHip1R binds to F-actin in a specific, saturable, and
concentration-dependent manner with a relatively high af-
finity.
mHip1R Shows a Punctate Perinuclear and Cortical 
Subcellular Localization
The antibody raised against mHip1R (aa 1032–1068) was
used to study its subcellular localization in different cell
lines. This antibody labeled punctate structures that
were enriched at the cell cortex and excluded from the
nucleus (Fig. 4, a–f). The punctate subcellular distribu-
tion was observed in all cell lines examined (COS-7,
NIH/3T3 fibroblasts, MDCK, and PC12). The mHip1R-
positive staining is also enriched in the perinuclear re-
gion, where it often appears more continuous (Fig. 4 a
and Fig. 5 d).
The cortical staining was present on all surfaces. Similar
results were obtained with polarized MDCK cells, in
which case the Hip1R staining was observed both on api-
cal and basolateral surfaces (data not shown). At the cell
Figure 3. The talin-like domain of mHip1R binds to F-actin. (a)
SDS-PAGE of a cosedimentation assay. The gels were stained
with Coomassie blue, where P represents the pellets and S repre-
sents the supernatants. 0–10 mM nonmuscle actin was used with a
constant concentration of GST-talin domain (1.5 mM). (b) Per-
centage of GST-talin domain bound to actin as a function of actin
concentration. GST alone was used as a control. This experiment
was repeated three times with similar results.Engqvist-Goldstein et al. Hip1R Endocytic and Cytoskeletal Protein 1509
periphery, Hip1R was also present in some F-actin–rich
membrane ruffles, where the staining appeared continu-
ous rather than punctate (Fig. 4, g–i). In these ruffles,
Hip1R partially colocalized with F-actin (Fig. 4 i). Since
mHip1R contains an actin-binding domain that is homolo-
gous to that of the focal adhesion protein talin, it was im-
portant to determine whether mHip1R also localizes to
focal adhesions. However, double-labeling with paxillin,
another focal adhesion protein, showed that mHip1R does
not localize to focal adhesions (data not shown). In sum-
mary, mHip1R shows a punctate staining pattern and is
enriched at the cell cortex and in the perinuclear region,
and is present in some membrane ruffles.
mHip1R Colocalizes with Markers for
Receptor-mediated Endocytosis
The yeast homologue of mHip1R (Sla2p) is required for
endocytosis and localizes to cortical patches that partially
overlap with actin patches. Because of the limited resolu-
tion in yeast cells, it has been difficult to determine
whether Sla2p colocalizes with components of the en-
docytic machinery. To address this question in mammalian
cells, we examined whether the punctate structures stained
by the anti-mHip1R antibodies are also recognized by dif-
ferent markers for receptor-mediated endocytosis. We
first tested whether mHip1R colocalizes with the coat pro-
tein, clathrin, which is involved in budding of vesicles from
Figure 4. Indirect immuno-
fluorescence of endogenous
Hip1R in COS-7 cells. (a, d,
and g) Labeling of Hip1R by
GP#8 and anti–guinea pig
FITC secondary antibody. (b,
e, and h) F-actin staining la-
beled by rhodamine-phalloi-
din. (c, f, and i) Overlay be-
tween Hip1R and F-actin. In
c this merge also includes 4,6-
diamidino-2-phenylindole di-
hydrochloride staining to la-
bel the nucleus. Bars, 10 mM.
(a–c) Punctate vesicle-like
Hip1R localization that is en-
riched in the perinuclear area
(a, arrow). (d–f) Hip1R-posi-
tive puncta are enriched at
the actin-rich cell cortex as
demonstrated by confocal mi-
croscopy sectioning through a
medial plane of a clump of
cells. (g–i and enlargements)
Hip1R is present in some
F-actin–rich ruffles, where
the staining is less punctate
and more continuous and
colocalizes partially with
F-actin. Confocal images
close to the cell attachment
surface.The Journal of Cell Biology, Volume 147, 1999 1510
the plasma membrane and from the TGN (for review see
Hirst and Robinson, 1998). mHip1R and clathrin showed
an overall similar subcellular distribution and colocaliza-
tion. Both are enriched in the perinuclear region (Fig. 5, a–c).
The mHip1R and clathrin perinuclear colocalization is es-
pecially evident when examined by confocal microscopy
(Fig. 5, d–f). Additionally, the cortical mHip1R and clath-
rin staining colocalized (Fig. 5, g–i). The only marked dif-
ference in the staining patterns of mHip1R and clathrin
was in membrane ruffles, structures in which mHip1R, but
not clathrin, is present (Fig. 5 a, arrow). We also tested
whether mHip1R colocalizes with the adaptor protein AP-2,
which is involved in budding from the plasma membrane
during clathrin-mediated endocytosis. As shown in Fig. 5,
j–l, the staining pattern of mHip1R is almost identical to
that of AP-2, except that AP-2 was not detected in the
perinuclear region or in membrane ruffles.
Next, we tested whether Hip1R colocalizes with trans-
ferrin-labeled endosomal compartments in COS-7 cells.
Pulse–chase experiments using Texas red–labeled trans-
ferrin showed that Hip1 partially colocalizes with en-
docytic compartments (Fig. 6). At 2–5 min uptake, trans-
Figure 5. mHip1R colocal-
izes with clathrin and AP-2 in
COS-7 and NIH/3T3 fibro-
blasts. (a, d, g, and j)
mHip1R. (b, e, and h) Clath-
rin. (k) AP-2. (c, f, i, and l)
Overlay. (a–c) COS-7 cells.
mHip1R and clathrin show a
similar subcellular distribu-
tion, including enrichments
in the perinuclear areas. Bar,
10 mM. (d–f and insets) Con-
focal microscopy of COS-7
cells. mHip1R largely colo-
calizes with clathrin in the
perinuclear region. Bar, 5
mM. (g–i and enlargements)
NIH/3T3 cells. mHip1R par-
tially colocalizes with clathrin
at the cell cortex. Bar, 10 mM.
(j–l) COS-7 cells. Colocaliza-
tion of mHip1R and AP-2.
Bar, 10 mM.Engqvist-Goldstein et al. Hip1R Endocytic and Cytoskeletal Protein 1511
ferrin shows a rather continuous labeling of the cell cortex,
and it is difficult to discern any individual puncta (Fig. 6
b). Hip1R-positive puncta at the cell cortex overlap with
this cortical transferrin staining (Fig. 6, a–c). After 5–15
min uptake, transferrin showed a punctate staining that
partially colocalizes with Hip1R (Fig. 6, d–f). At later
stages of uptake (15–60 min), transferrin labels larger
endosomal compartments, possibly recycling endosomes
and/or late endosomes. These endosomal compartments
show much less Hip1R staining (data not shown). In sum-
mary, mHip1R colocalizes with clathrin, AP-2, and with
transferrin-labeled early endocytic compartments.
mHip1R Is a Peripheral Membrane Protein that Is 
Enriched in Clathrin-coated Vesicle Fractions
Since mHip1R colocalized with markers for receptor-medi-
ated endocytosis, it was important to determine whether
mHip1R is tightly associated with clathrin-coated vesicles.
We first determined by subcellular fractionation whether
mHip1R is a soluble or peripheral membrane protein. As
shown in Fig. 7 a, the majority of mHip1R associates with
the particulate fractions (P1, P2, and P3), and a very small
pool is soluble (S3). This distribution is different from that
of other cytoskeletal proteins like paxillin and Abp1, but it
is very similar to that of clathrin (Fig. 7 and data not
shown). mHip1R can be extracted from the particulate
fraction with 0.5 M NaCl, indicating that mHip1R is a pe-
ripheral membrane protein and not an integral membrane
protein (Fig. 7 a, lanes 9 and 10). In addition, extraction of
P2 with the nonionic detergent Triton X-100 showed that a
pool of mHip1R is Triton X-100–insoluble (Fig. 7 a, lanes
7 and 8), a characteristic shared by many cytoskeletal
membrane proteins. These fractionation properties are
similar to those of yeast Sla2p and human Hip1 (Kalch-
man et al., 1997; Wesp et al., 1997).
Figure 6. Hip1R partially
colocalizes with transferrin-
labeled endocytic compart-
ment in COS-7 cells. (a and
d) mHip1R. (b and e) Trans-
ferrin–Texas red. (c and f)
Overlay. (a–c) At 2 min of
uptake, transferrin labels the
cell cortex (confocal me-
dial section of cell clump).
Hip1R-positive puncta over-
laps with this cortical stain-
ing. (d–f and enlargements)
At 10 min of transferrin up-
take, Hip1R partially colocal-
izes with transferrin-labeled
endocytic compartment. The
confocal images are showing
a section close to the attach-
ment surface as observed by
confocal microscopy. Bars,
10  mM.The Journal of Cell Biology, Volume 147, 1999 1512
Because the association of mHip1R with P2 and P3
could reflect association with endosomes and vesicles, we
next examined whether mHip1R copurifies with clathrin-
coated vesicles. Clathrin-coated vesicles were purified
from mouse brain, and as shown in Fig. 7 c, mHip1R was
highly enriched in this preparation, similar to clathrin.
Coomassie staining (Fig. 7 b) shows that clathrin was a
major component of this vesicle fraction, and that we
achieved a clathrin-coated vesicle purity similar to that de-
scribed previously in the literature (Lindner, 1998). This
fraction contained no detectable levels of BiP1, which is a
protein resident in the ER (Fig. 7 c), or any detectable lev-
els of syntaxin 1, which is a protein resident in the plasma
membrane (data not shown). Other known components of
clathrin-coated vesicles, Eps15 and Amphiphysin 2, were
present in this preparation, although they did not appear
enriched to the same extent as mHip1R (Fig. 7 c). Other
cytoskeletal proteins like mAbp1 and paxillin were not de-
tected in the clathrin-coated vesicle preparation (Fig. 7 c
and data not shown).
mHip1R Contains Cytoskeletal and Endocytic 
Localization Signals
The in vitro actin binding assay and the subcellular frac-
tionation results suggested that mHip1R associates with both
the actin cytoskeleton and components of clathrin-coated
vesicles. To identify which domain(s) are responsible for
these interactions in vivo, we determined the subcellular
localization of different mHip1R fragments expressed in
COS-7 cells (Fig. 8 a). The fragments were tagged with
myc and/or with GFP. Each of these constructs expressed
a stable protein that migrated on SDS gels at the predicted
molecular weight (Fig. 8 b).
Both mHip1R (aa 1–1068)–GFP and mHip1R (aa
1–1068)–6 myc showed a punctate subcellular localization
similar to the endogenous protein (Fig. 8, c and d). In addi-
tion, analysis of mHip1R (aa 1–1068)–GFP revealed a lo-
calization similar to the endogenous protein at membrane
ruffles (data not shown). This analysis was confined to
cells expressing lower levels of the tagged proteins, be-
cause in cells expressing higher levels, the specific staining
is obscured by the increased cytosolic staining. The ob-
served staining patterns and the fact that these full-length
constructs colocalized with endogenous clathrin and AP-2
(data not shown) suggested that the tags did not interfere
with mHip1R localization.
In contrast to the full-length protein, mHip1R (aa 766–
1068)–GFP, which expresses the talin-like domain alone,
did not show a punctate staining pattern but instead
showed continuous staining enriched at the cell cortex.
That mHip1R (aa 766–1068)–GFP colocalized with F-actin
is especially evident in membrane ruffles in COS-7 cells
(Fig. 8 e). This result is consistent with the in vitro actin
binding assay, showing that this talin-like domain copellets
with F-actin. This construct also showed some nuclear
staining even at low expression levels. mHip1R (aa 346–
Figure 7. mHip1R is a peripheral membrane protein that cofrac-
tionates with clathrin-coated vesicles. (a) Subcellular fraction-
ation of mHip1R. Different fractions of mouse brain homogenate
were resolved by SDS-PAGE and examined for the indicated
proteins by immunoblotting. The P2 fractions were extracted un-
der different conditions as indicated in the figure. For each pellet
(P) and supernatant (S) fraction, equal amounts of protein were
loaded. (b and c) Purification of clathrin-coated vesicles from
mouse brain homogenate. Fraction (V) represents enriched
clathrin-coated vesicles. Equivalent portions of S1, P2, and S2
were loaded (z0.02% of the fraction), and equivalent portions of
S3, P3, S4, and V were loaded (z2% of the fraction). (b) Coo-
massie-stained gel of the fractions. Arrow indicates the band cor-
responding to the clathrin–heavy chain enriched in the vesicle
fraction. (c) Immunoblotting of fractions.Engqvist-Goldstein et al. Hip1R Endocytic and Cytoskeletal Protein 1513
1068)–GFP, which expresses the talin-like domain and the
central, large coiled–coil domain, showed a similar subcel-
lular distribution to that of the talin-like domain alone, al-
though the cortical staining was less pronounced (Fig. 8 f).
mHip1R (aa 766–1068) and mHip1R (aa 346–1068) were
also expressed with a 6 myc-tag. These constructs showed
a similar distribution to the GFP constructs, but the corti-
cal staining was less pronounced (data not shown). The
NH2-terminal domain (mHip1R [aa 1–324]–6 myc), which
in yeast has been shown to be important for endocytosis
(Wesp et al., 1997), showed cytosolic staining when ex-
pressed with a myc-tag (Fig. 8 g). When expressed as a
GFP fusion (mHip1R [aa 1–324]–GFP), this construct also
localized to the nucleus (data not shown). In contrast,
mHip1R (aa 1–655)–6 myc, which expresses the NH2-ter-
minal domain and the first, central coiled–coil domain,
Figure 8. Expression of
mHip1R domains in COS-7
cells reveals that mHip1R
contains at least two differ-
ent localization signals. Full-
length and different domains
of mHip1R were expressed
as GFP fusion proteins
and/or  myc-tagged proteins.
(a) Schematic diagram of
mHip1R domains expressed.
(b) Immunoblotting of ex-
tracts from cells expressing
the different mHip1R con-
structs. GFP fusion proteins
were detected with anti-GFP
antibodies. myc-tagged pro-
teins were detected with anti-
myc antibodies. (c–h) The
upper panels show subcellu-
lar localization of the con-
structs. The lower panels
show rhodamine-phalloidin
staining of F-actin in the
same cells. (c) mHip1R (aa
1–1068)–GFP. (d) mHip1R
(aa 1–1068)–6 myc. (e)
mHip1R (aa 766–1068)–
GFP. (f) mHip1R (aa 346–
1068)–GFP. (g) mHip1R
(aa  1–324)–6 myc. (h)
mHip1R  (aa 1–655)–6 myc.
Bars, 10 mm.The Journal of Cell Biology, Volume 147, 1999 1514
shows a punctate localization similar to the endogenous
protein (Fig. 8 h). This construct also colocalized with
clathrin and AP-2 (data not shown). These results show
that the talin-like domain is not required for localization
with the endocytic machinery.
Visualization of mHip1R-GFP in Detergent-extracted 
and Live Cells
Next, we investigated the dynamics of mHip1R in live
cells. It has been shown previously that clathrin-coated
pits labeled with GFP–clathrin are retained in unfixed, de-
tergent-extracted cells (Gaidarov et al., 1999). To test
whether mHip1R-labeled puncta behave like coated pits,
we observed mHip1R–GFP in COS-7 cells before and af-
ter treatment with Triton X-100. As shown in Fig. 9, a and
b, the majority of mHip1R-GFP–labeled puncta at the cell
cortex were retained in extracted cells. In contrast, the
perinuclear staining and the cytosolic staining were lost
upon Triton X-100 treatment. These results are similar to
those obtained from studies on GFP–clathrin (Gaidarov
et al., 1999). To test whether mHip1R-labeled puncta ex-
hibit dynamic behavior similar to that described previ-
ously for GFP–clathrin (Gaidarov et al., 1999), we ob-
served individual puncta at the cell cortex at 1.5-s intervals
over 45 frames. During this 67.5-s interval, z60% of the
puncta remained in the same relative location. In contrast,
some new puncta appeared, whereas z40% of the puncta
present in the first frame disappeared or were greatly di-
minished in subsequent images (Fig. 9 c). As with the ob-
servations for clathrin-GFP, some puncta disappeared
abruptly, whereas others showed a more gradual change in
intensity (compare disappearing puncta in Fig. 9).
Given the fact that mHip1R was also present in lamelli-
podia, we next investigated the dynamics of mHip1R
puncta in lamellipodia of motile NIH/3T3 fibroblasts.
Lamellipodia are regions of high membrane and actin dy-
namics. These regions are relatively flat, thus facilitating
the visualization of individual puncta over extended areas
of the cell. In these lamellipodia, mHip1R–GFP puncta
were observed in addition to some staining at the leading
edge (Fig. 10). The majority of these mHip1R–GFP
puncta were motile and moved from the leading edge to-
wards the center of the cells (Fig. 10 a). Random move-
ments were rarely observed. These directed movements
were not observed in COS-7 cells. However, COS-7 cells
do not form any extended lamellipodial protrusions. The
motile puncta showed a net rate of movement of z0.5–3.0
mm/min inward from the cell periphery. The fastest move-
ments were observed within a zone extending z5 mm in
from the cell edge. As shown in Fig. 10 a, puncta further
away from the cell edge often appeared to be aligned on
linear tracks. These puncta moved slowly inwards at a uni-
form rate (,1 mm/min). To test whether the movement of
the puncta in lamellipodia was dependent on F-actin, we
observed individual cells before and after treatment with
LAT-A, a monomer-sequestering drug that causes depoly-
merization of actin filaments (Coué et al., 1987; Spector et al.,
1989). Before treatment with LAT-A, individual puncta
moved inwards from the cell periphery (Fig. 10 b). 5–10
min after adding LAT-A, these puncta no longer showed
net movement away from the cell periphery. They were ei-
ther stationary or were moving in a random fashion (Fig.
10 c).
Discussion
The actin cytoskeleton has been implicated in endocytosis,
yet few direct links between the actin cytoskeleton and the
endocytic machinery have been established. Here, we
show that mHip1R, a mouse homologue of yeast Sla2p, as-
Figure 9. Time-lapse video
microscopy of mHip1R–GFP
in COS-7 cells. (a and b) The
distribution of mHip1R–GFP
in a cell before (a) and 45 s
after (b) addition of Triton
X-100 shows that the cortical
staining is retained in ex-
tracted cells. Bar, 10 mm. (c)
Images at 1.5-s intervals
show that mHip1R–GFP
puncta exhibit dynamic be-
havior. Changes in individ-
ual mHip1R–GFP puncta
throughout this series of im-
ages are summarized in the
diagram to the right, in which
persistent (filled circles), dis-
appearing (open circles), and
appearing (asterisks) puncta
are indicated. Bar, 2.5 mm.Engqvist-Goldstein et al. Hip1R Endocytic and Cytoskeletal Protein 1515
sociates with both actin filaments and clathrin-coated pits
and vesicles.
Sequence alignments and secondary structure predic-
tions clearly show that mHip1R belongs to the Sla2 family
of proteins. Furthermore, we suggest that this protein is an
ortholog of human Hip1R, because these two proteins
show high sequence identity and similar ubiquitous tissue
distribution. In contrast, Hip1 is predominantly expressed
in the brain (Kalchman et al., 1997).
Our biochemical and colocalization studies demon-
strated that mHip1R associates with clathrin-coated vesi-
cles. Since mHip1R colocalized with AP-2 at the cell cor-
tex and shows spatial overlap with transferrin-labeled
endocytic compartments at early stages of uptake, we con-
clude that mHip1R is a component of both clathrin-coated
vesicles and clathrin-coated pits. In support of the associa-
tion of mHip1R with clathrin-coated pits, we showed in
COS-7 cells that puncta at the cell cortex labeled with
mHip1R–GFP exhibit similar behavior to that reported
previously for puncta labeled with clathrin–GFP in this
cell type (Gaidarov et al., 1999). That is, in both cases the
puncta remained relatively stationary, but their signal
intensities changed dramatically, with puncta disappear-
ing  and appearing over time. Furthermore, the cortical
mHip1R staining is resistant to extraction with Triton
X-100, a property shared with clathrin–GFP (Gaidarov et
al., 1999).
It is interesting that mHip1R is not only enriched at the
Figure 10. Time-lapse video
microscopy of mHip1R–GFP
in NIH/3T3 fibroblasts. (a–c)
The first image in each series
shows a low magnification
overview of the cell. Bars in
the figures serve as stationary
reference points. (a) Images
taken at 20-s intervals show
movement of mHip1R–GFP
away from the cell periphery
(see arrows and arrowheads).
Puncta further away from the
cell periphery often appear to
align on linear tracks (see ar-
rows). Bar, 10 mm. (b) Cell
before treatment with LAT-A.
Puncta are moving inwards
from the cell periphery (see
arrows and arrowheads). (c)
Same cell 5 min after adding
LAT-A. The puncta no
longer show a net movement
away from the cell periph-
ery. Bar, 10 mm.The Journal of Cell Biology, Volume 147, 1999 1516
cell cortex but also in the perinuclear region, another re-
gion of clathrin localization. Clathrin is involved not only
in endocytosis but also in budding of exocytic vesicles
from the TGN (Robinson, 1987; Ahle et al., 1988). The
perinuclear staining of mHip1R is sensitive to treatment
with brefeldin A and nocodazole (data not shown), sug-
gesting that this immunostaining represents the TGN.
Thus, mHip1R may function both in clathrin-mediated
endocytosis and in clathrin-mediated budding from the
TGN. Currently, the molecular function of mHip1R in
these processes is not known. However, it is important to
note that both pathways involve formation of invagina-
tions of membrane, coat assembly, and vesicle fission, pro-
cesses for which a related machinery is used (for review
see Hirst and Robinson, 1998). Not only does the coat con-
tain clathrin in both cases, but the adaptor complexes em-
ployed are related (AP-2 at the plasma membrane and
AP-1 at the TGN). It is attractive to speculate that
mHip1R may be capable of interacting in a similar manner
with the related vesicle budding machinery that mediates
endocytosis and TGN vesicle budding. It is worth noting
that huntingtin protein has also been identified as a com-
ponent of clathrin-coated vesicles (Velier et al., 1998), sug-
gesting Hip1 and/or Hip1R and huntingtin might function
together in clathrin-mediated processes.
mHip1R is a modular protein with several conserved
domains that could potentially interact with other pro-
teins. The talin-like domain is the most conserved se-
quence among Sla2p family members. Here, we showed
that this domain of mHip1R binds to F-actin in vitro and
colocalizes with F-actin in vivo. This demonstrates that
F-actin binding is a conserved activity between mHip1R
and yeast Sla2p (McCann and Craig, 1997). Deletion of
the talin-like domain in Sla2p has only a subtle effect on
actin cytoskeleton organization and does not appear to af-
fect endocytosis, whereas overexpression of this domain
causes dramatic defects in actin organization, with an in-
crease in F-actin structures (Wesp et al., 1997; Yang et al.,
1999). Yang et al. (1999) concluded that this domain may
provide functions redundant with that of the Sla2 NH2 ter-
minus. More work is required to fully elucidate the func-
tion of the mHip1R talin-like domain.
We show that within the NH2-terminal part of the pro-
tein, mHip1R contains a second localization signal that is
important for association with the endocytic machinery.
The NH2-terminal domain alone showed a nonvesicular
cytosolic and nuclear staining, whereas the NH2-terminal
domain plus the coiled–coil domain localized in a manner
similar to the full-length protein. This observation suggests
that the central coiled–coil domain contains the signal, or
that both domains are needed simultaneously. We favor
the latter possibility, because expression of the coiled–coil
domain together with the talin-like domain does not show
a punctate staining but instead shows colocalization with
F-actin. One possibility is that the NH2-terminal domain
plus the central coiled–coil domain dimerizes with the en-
dogenous protein. In yeast Sla2p, the NH2-terminal do-
main has been shown to be essential for receptor-medi-
ated endocytosis, whereas other domains are dispensable
(Wesp et al., 1997). The NH2-terminal deletion mutant
also had defects in cell morphology and organization of
the actin cytoskeleton (Wesp et al., 1997). Interestingly,
Wesp et al. (1997) showed that a mutant lacking the cen-
tral coiled–coil domain in Sla2p in combination with dele-
tion of either Abp1p or Srv2p, also caused a defect in re-
ceptor-mediated endocytosis. ABP1 and SRV2 are genes
encoding two actin-binding proteins whose null alleles are
synthetic lethal with sla2D, indicating that these proteins
may perform redundant functions (Holtzman et al., 1993;
Lila and Drubin, 1997). Therefore, we concluded that the
NH2-terminal domain and the central coiled–coil domain
are involved in endocytosis, and that the latter domain
may be functionally redundant with either Abp1p or
Srv2p. This conclusion is consistent with our observation
that both the NH2-terminal domain and the central coiled–
coil domain are required for localization to clathrin-coated
pits and vesicles.
As discussed above, full-length mHip1R did not show a
subcellular localization that is typical of F-actin binding
proteins. Instead, it appears to be tightly associated with
clathrin-coated vesicles and pits. However, endocytosis oc-
curs at the actin-rich cell cortex. There, membrane-associ-
ated mHip1R could bind to the actin cytoskeleton directly.
A further indication of the relevance of mHip1R actin as-
sociation is the fact that the endogenous protein is present
in some membrane ruffles, where it partially colocalizes
with the actin cytoskeleton. It has been shown previously
that depolymerization of the actin cytoskeleton inhibits re-
ceptor-mediated endocytosis in some cell types (Gottlieb
et al., 1993; Lamaze et al., 1997), and it has been specu-
lated that the actin cytoskeleton may provide a force re-
quired for budding and/or provide a scaffold for the en-
docytic machinery. The function of mHip1R could be to
link the actin cytoskeleton to coated pits to facilitate vesi-
cle budding.
The actin cytoskeleton might also be involved in the
transport of vesicles away from the plasma membrane.
There is evidence that pinocytic vesicles associate with ac-
tin tails, and it has been proposed that endocytic vesicles
and pinosomes move into the cytosol by means of a brief
burst of actin polymerization, analogous to the movement
of Listeria and Shigella (Merrifield et al., 1999). Recently,
two proteins that are known to affect actin dynamics have
also been shown to associate with components of the en-
docytic machinery. First, N-WASP, a protein that can
stimulate the nucleation activity of the Arp2/3 complex
(Rohatgi et al., 1999), has been shown to interact with syn-
dapin I (Qualmann et al., 1999). Syndapin I is an src ho-
mology domain 3 (SH3)-containing brain protein that
binds to the GTPase dynamin I (Qualmann et al., 1999),
the protein that controls the vesicle fission event in recep-
tor-mediated endocytosis (for review see Schmid et al.,
1998). Second, profilin, a G-actin binding protein that is
important for regulation of actin assembly, has been
shown to bind to dynamin 1 in vitro and to colocalize with
dynamin I in hippocampal neurons (Witke et al., 1998).
Profilin is also capable of binding to inositol phosphates
(Witke et al., 1998), leading to the speculation that cluster-
ing of phospholipids into local domains of the plasma
membrane might be a common mechanism to regulate
cortical actin assembly as well as membrane flow. In our
study, we presented evidence that mHip1R-containing
coated pits and/or vesicles move by an actin-dependent
mechanism in NIH/3T3 fibroblasts. Punctate structures la-Engqvist-Goldstein et al. Hip1R Endocytic and Cytoskeletal Protein 1517
beled with mHip1R–GFP moved inward from the cell pe-
riphery in lamellipodia, and this directed movement was
inhibited by LAT-A. Our data suggest that mHip1R is an-
other component linking the actin cytoskeleton to sites of
endocytosis. Therefore, mHip1R is a candidate to facili-
tate this movement.
In yeast, genetic and biochemical data have suggested
that Sla2p, along with Abp1p, Srv2p, and Rvs167p, partici-
pate in the early stage of endocytosis (for review see
Wendland et al., 1998). Abp1p binds both to Rvs167p and
to Srv2p (Freeman et al., 1996; Lila and Drubin, 1997). In
addition,  sla2D is synthetic lethal with mutants of the
genes encoding each of these proteins (Holtzman et al.,
1993; Lila and Drubin, 1997). Rvs167p is related to the
mammalian protein amphiphysin, which is a protein known
to be involved in receptor-mediated endocytosis (for re-
view see Wigge and McMahon, 1998). Srv2, on the other
hand, is a protein implicated in cAMP and Ras signaling
(Fedor-Chaiken et al., 1990; Field et al., 1990). Sla2p also
has been recently implicated by yeast two-hybrid interac-
tions in signaling to the actin cytoskeleton by binding to
the Ser/Thr kinase Ark1p (Cope et al., 1999). Ark1p
shows genetic interactions with Prk1p, a homologous ki-
nase, which in turn shows genetic interactions with both
Sla2p and Abp1p (Cope et al., 1999). Thus, in yeast a net-
work of physical and genetic interactions involving ki-
nases, cortical actin patch proteins, and components of the
endocytic machinery is emerging (Wendland et al., 1998;
Cope et al., 1999). For most of these yeast proteins, related
proteins in mammals are known. For example, we have re-
cently identified and characterized mAbp1, a mouse pro-
tein related to yeast Apb1p (Kessels et al., 2000). Further
studies drawing on the complementary experimental ad-
vantages of yeast and mammalian cells will provide in-
sights into the molecular role of mHip1R, and will reveal
the function of the actin cytoskeleton in endocytosis.
These studies may also provide insights into the etiology
of Huntington disease.
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